Adlai Nortye is a global clinical-stage biotechnology company that is developing differentiated, innovative immuno-oncology medicines with the vision of becoming a world-class biopharmaceutical company. We have successfully established a world-class senior management team and core R&D team. With strong capital, excellent oncology pipeline, rich product development experience and international vision, Adlai Nortye will become the preferred partner of multinational pharmaceutical /biopharmaceutical companies.
Our vision Our vision
Address: 21 F, Building 2, No.452, 6th Street, Economic &Technological; Development Area, Hangzhou, China, 310018